Novo Nordisk is planning to expand its operations in Ireland in order to make the Wegovy weight-loss drug in tablet form for markets outside the US. The pharmaceutical company will extend its manufacturing facility in Athlone, Co Westmeath, chief executive Mike Doustdar has told Bloomberg. About two years ago, Novo Nordisk pulled out of plans to build a factory near Dublin. The launch of the Wegovy pill in early January has been one of the most successful pharmaceutical debuts ever, with more than 240,000 Americans taking it, Mr Doustdar said. Last October, the company appointed Dilek Dogan Gurluk as general manager of Novo Nordisk Ireland.

Source: Irish Independent February 12, 2026 20:34 UTC